Sulmazole

This classification denotes a cardiotonic agent with the molecular formula C14H13N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HK56EH9K44, chemically known as 2-(2-methoxy-4-(methylsulfinyl)phenyl)-1h-imidazo(4,5-b)pyridine but generally known as sulmazole, which bears US NIH Compound Identifier 5353. European Medicines Agency schedules Sulmazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10748MIG. The term SULMAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). SULMAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulmazole under HS 29339990 and SITC 51577. As of Q4 2014, SULMAZOLE remains the US FDA Preferred Term for this commodity. Sulmazole bears US NLM identifiers UMLS ID C0075619 and NCI Concept Code C84188. SMILES: S(=O)(C1CC(OC)C(C2[NH]C3C(N2)NCCC3)CC1)C.